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Background: We found previously that the expression of SET gene was up-regulated in polycystic ovaries.
Evidences suggested that SET protein was essential for regulating both the promoter activity of CYP17A1 and the
biological activity of P450c17. In this study, we explored whether SET regulated androgen production in preantral
follicles.
Methods: The mouse preantral follicles were cultured in vitro. Testosterone secretion and expression of
steroidogenic enzymes were observed in the preantral follicles treated in vitro by SET overexpression and
knockdown.
Results: Testosterone levels in the media of the AdCMV-SET infected follicles significantly increased, and the
CYP17A1 and HSD3B2 expression also significantly increased (P < 0.05). Testosterone levels in AdSiRNA-SET infected
group decreased, and so did CYP17A1 and HSD3B2 expression (P < 0.05).
Conclusions: SET played a positive role in regulating ovarian androgen biosynthesis by enhancing the transcription
of steroidogenic enzymes CYP17A1 and HSD3B2, which maybe contribute to the hyperandrogenism in PCOS.
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The ovarian follicle develops as a functional unit which
comprises of theca cells, granulosal cells, and oocyte.
The theca cells are the primary source to synthesize an-
drogen in response to LH [1-3]. Besides, the synthesis of
androgen in theca cells is also regulated by a variety of
additional steroidogenic enzymes. It is well known that
theca cells express cytochrome P450 cholesterol side-
chain cleavage enzyme (P450scc), 3β-hydroxysteroid
dehydrogenase (HSD3B2), and cytochrome P450 cyto-
chrome P450 17α-hydroxylase (CYP17A1) which has
both 17α-hydroxylase and C17, 20 lyase activities [4]. All
of these are key enzymes for androgen synthesis. In
addition, steroidogenic acute regulatory (StAR) protein
which facilitates cholesterol entry into the mitochondria
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reproduction in any medium, provided the orandrogen [5]. The regulation of these enzymes plays a
critical role in normal androgen production and plays a
proposed role in the pathogenic hyperandrogenic
conditions such as Polycystic Ovarian Syndrome (PCOS)
[6,7].
The SET protein (patient “SE translocation”), also
known as TAF-1β [8], I2PP2A [9] and INHAT [10],
belongs to a family of multitasking proteins, which is
involved in apoptosis, transcription, nucleosome assembly,
and histone binding. SET is located in chromesome 9q34
and encodes a 39 KDa phosphoprotein. It was originally
identified as a translocated gene in acute undifferentiated
leukemia [11]. In addition, as a transcriptional regulating
factor, SET not only exerts by binding to the transcrip-
tional co-activators CBP/p300 [12], but also acts directly
as a transcriptional factor of CYP17A1 [13]. SET-mediated
promoter hypoacetylation is a prerequisite for co-
activation of the estrogen-responsive pS2 gene by PRMT1
[14]. SET is widely expressed in various tissues, especially
in steroidogenic cells within the central nervous system,
adrenal glands, and gonads [13,15,16]. In rat ovaries, SETThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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human ovaries we found that SET protein also expressed
predominantly in theca cells and oocytes (unpublished
data). Recent evidence suggested that SET was essential
for regulating both the promoter activity of CYP17A1 and
the biological activity of P450c17. In human NT2 neur-
onal precursor cells and MA-10 cells, SET binds to rat
CYP17A1 promoter at −418/-399 and activates its basal
transcription from a rat CYP17A1 luciferase reporter plas-
mid [13,15,17]. In addition, SET has been identified as a
potent inhibitor of the protein phosphatase 2A (PP2A).
Miller et al. showed that, in NCI-H295A cells, SET can
foster 17, 20 lyase activity of P450c17 by inhibiting the
dephosphorylation action of PP2A on P450c17 [18], be-
cause the phosphorylation of P450c17 on serine and
threonine residues increases its17, 20 lyase activity
through as-yet-unidentified mechanisms, which may
involve in increasing its affinity for b5 and/or P450
oxidoreductase [19].
Although the function of SET protein in some
steroidogenic cells such as adrenal glands cells has been
partly studied, the role of SET in androgen biosynthesis
of ovarian theca cells has not been explored previously.
Our previous studies have also found that SET was
one of the overexpressed genes in polycystic ovaries
compared to normal ovaries using cDNA microarray
technology [20]. All of these attracted us to explore the
function of SET in the regulation of ovarian androgen
biosynthesis. This study may also help us to understand
the pathophysiological role of SET in hyperandrogenism
of PCOS.
Methods
Construction of recombinant adenovirus
The recombinant adenovirus was constructed using the
AdEasy system [21]. Briefly, the cDNA sequence of SET
was cloned by reverse transcriptive polymerase chain re-
action (RT-PCR), and then subcloned into pAdTrack-
CMV. The AdCMV-SET was recombined with backbone
pAdEasy-1 in BJ5183 bacteria. The recombined adeno-
virus AdCMV-SET was generated and amplified in 293A
cells. The titer of the viral stock was determined by the
tissue culture infectious dose (TCID50) method. At the
same time, the adenovirus of AdCMV was generated
using “empty” pAdTrack-CMV vector as the control.
For endogenous SET knockdown experiments, the
recombinant adenoviruses AdsiRNA -SET delivering
siRNA targeting SET and AdsiRNA-Scrambled (control)
viruses were constructed as previously described, with
some modifications [22]. The potential target sequences
for RNA interference were scanned with the siRNA Tar-
get Finder and Design Tool available on the Ambion
Inc. website. The target sequence was as follows, SET
SiRNA: 50-ATATAACAAACTCCGCCAA-30 (sense),SET Scramble: 50-GAGACGTCAACTCCAACAC-30.
The target sequence was inserted into plasmid pShuttle-
H1. The fragment H1-SiRNA/SET was digested and
inserted into the plasmid pAdTrack-CMV to construct a
shuttle plasmid containing reporter gene of green fluor-
escent protein (GFP). AdSiRNA-SET was recombined
with backbone pAdEasy-1 in BJ5183 bacteria. The
adenovirus of AdSiRNA-NS was constructed at the same
time. Adenovirus generation, amplification, and titers
were performed according to the methods described
above.
Follicle isolation and culture
All animal procedures were approved by the Institu-
tional Animal Care and Use Committee of Jiangsu Prov-
ince and were performed in accordance with the Guide
for the Care and Use of Laboratory Animals. Our follicle
culture in vitro methods had been established previously
[23,24]. Briefly, ovaries were dissected immediately from
20-day-old female mice (Animal Centre of Nanjing
Medical University, Nanjing, China) and transferred to
the dissection medium, consisted of L-15 Leibovitz
GlutaMAX (Gibco-BRL, Cergy-Pontoise, France) supple-
mented with 10% FCS, 100 IU/ml penicillin, and 100 μg/
ml streptomycin that was prewarmed and maintained at
37C. Ovaries were cleaned of connective tissues, and
individual preantral follicles of 180–200 μm in diameter
were isolated by manual dissection using 28.5-gauge
needles (Becton Dickinson, Erembodegem, Belgium).
Follicles were then transferred to the culture medium
consisting of α-minimal essential medium (α-MEM;
Gibco-BRL), 10% FCS, 100 mIU/ml recombinant follicle
stimulating hormone (FSH; Gonal-F; Serono, Switzer-
land), and ITS with 5 mg/ml insulin, 5 mg/ml transfer-
rin, and 5 ng/ml selenium (Sigma, USA). Only round
follicles with intact basement membranes and theca
layers were selected and placed individually in 96-well
plates with 100 μl culture medium in each well and
cultured at 37C in a humidified atmosphere containing
5% CO2. Each treatment, respectively, was added in cul-
ture medium, as described in the results section. Specific
treatments were performed in replicate and each experi-
ment was repeated at least three independent times with
a different preparation (pool) of follicles.
Follicle treatment with the recombinant adenoviruses
On the first day of follicle culture, the media was replaced
with fresh media. Recombinant adenoviruses AdCMV-
SET, AdCMV-GFP, AdSiRNA–SET, and AdSiRNA-
scrambled were then separately added to culture media
with a multiplicity of infection (MOI) of 100 and evenly
distributed by gentle shaking. Virus expression was
monitored by fluorescence microscopy showing green
fluorescent protein (GFP). The infected follicles cultured
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follicles in each group. At forty-eight hours after infection,
the follicles were collected separately and stored at −80C
for later Western blot analysis, with a total of 40 follicles
in each group. At the same time, the culture media of
those infected for 48 h, were collected and stored at
−80C for steroid content assay, with a total of 20 follicles
in each group. All experiments were repeated at least
three times.RNA extraction and qRT-PCR
RNA extraction of follicles was performed using the
RNeasy Plus Micro Kit (Qiagen Inc, Chatsworth, CA) and
total RNA was reverse transcribed with PrimeScript
Reverse Transcription reagent Kit (Perfect Real Time), as
described by the manufacturer. Amplification reactions
were conducted using SYBR Premix Ex Taq (Perfect Real
Time) with an ABI PRISM 7300 system. PrimeScript RT
reagent Kit (Perfect Real Time) and SYBR Premix Ex Taq
(Perfect Real Time) were purchased from TaKaRa
Biotechnology (TaKaRa [Dalian] Co. Ltd, Dalian, China).
Gene-specific qRT-PCR primers were used as listed in
Table 1. GAPDH was employed as an internal control to
normalize the loading templates of cDNA. Melting curve
analysis was performed to confirm the specificity of qRT-
PCR products. Each sample was assayed in duplicate and
the fold changed in expression of each interested gene was
analyzed via the 2-ΔΔCt method.Hormone assays
Testosterone level in the collected media was assessed using
the radioimmunoassay (RIA) kits (Beifang Biotechnique
Institute, Beijing, China) according to the manufacturer’s
protocol. The RIA kits were sensitive (<0.02 ng/ml) and re-
producible (total coefficient of variation [CV], <10%) with
measurement range from 0.1 to 20 ng/ml.Table 1 Primers used for qRT-PCR












(mouse) ReverseWestern blot analysis
The concentrations of protein extracted from the cultured
follicles were measured by the Bradford method. Equal
amount of protein was loaded and separated by 12% SDS-
PAGE and then electroblotted onto Polyvinylidene fluor-
ide membrane (Bio-Rad, Hercules, CA). The membranes
were incubated with antibodies of target protein and
then with HRP-conjugated secondary antibodies (1:1000;
Beijing ZhongShan Biotechnology, China) and examined
by enhanced chemiluminescence (Amersham Biosciences,
Uppsala, Sweden). At last the results were analyzed by
Quantity One version 4.6.2 (Bio-Rad, USA). The first anti-
bodies used were: polyclonal antibody to human SET
protein at 1:1000 dilution from ABCAM (Cambridge
Science Park, Cambridge, UK); polyclonal antibody to
mouse SET protein at 1:1000 from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA); polyclonal antibody to
β-tublin (as working calibrator) at 1:2000 from ABCAM
(Cambridge Science Park, Cambridge, UK).
Statistical analysis
Data were expressed as mean ± SD from at least three
independent experiments. One-way ANOVA was used
for statistical comparison. Values were determined to be
significant when p < 0.05.
Results
SET overexpression promoted androgen production in
theca cells
The in vitro culture model of mouse preantral follicle
was used to study the effect of SET on testosterone
synthesis in theca cells. The recombinant adenovirus
AdCMV-SET was constructed to up-regulate SET ex-
pression in theca cells of follicles. The report gene GFP
was employed to indicate the efficiency of adenoviruses
infection. At 24 h of post-infection, more than 90% of
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tein in follicles was analyzed by Western blot. SET
protein in the follicles infected with AdCMV-SET was
increased when compared with that in the follicles
infected with AdCMV (p < 0.05, Figure 1B). To test
whether SET regulated androgen production, the culture
media of AdCMV-SET or AdCMV infected follicles were
collected to evaluate testosterone levels. Compared with
that in the AdCMV infected group, the testosterone
level in the AdCMV-SET infected group was signifi-
cantly increased (5.40 ± 0.80 ng/ml vs 10.09 ± 1.54 ng/
ml, p < 0.05) (Figure 1C). These results indicated that
SET promoted testosterone production in ovarian theca
cells.
SET knockdown suppressed androgen production in
theca cells
To further confirm the effect of SET in modulating an-
drogen synthesis in theca cells, analogous experiments
were performed using AdSiRNA-SET and AdSiRNA-NS
control adenoviruses. After 24 h of infection, more than
90% of theca cells were observed to express GFP
(Figure 2A). As anticipated, level of SET protein
was degraded about 43% in the follicles treated
with AdSiRNA-SET when compared to that in the
AdSiRNA-NS treated follicles (p < 0.05, Figure 2B).
When compared with that in control group, testosterone
accumulation in the media of AdSiRNA-SET infection
group was significantly decreased (5.64 ± 1.40 ng/ml vsFigure 1 Effect of SET overexpression on testosterone synthesis in th
adenoviruses. Follicles were infected with recombinant adenovirus AdCMV-
infected as judged by the expression of GFP under a fluorescence microsco
50 μm). (B) Western blot analysis of SET protein expression in follicles infec
level in the follicles infected with AdCMV-SET were increased 1.8 times wh
used as internal controls. (C) Effect of SET overexpression on testosterone s
AdCMV for 48 h. Compared with that in the AdCMV infection group, testos
follicles was significantly increased. Results are presented as Mean ± SD from
with AdCMV.1.49 ± 0.32 ng/ml, p < 0.05) (Figure 2C). This functional
study strongly demonstrated that SET protein had a
positive role in modulating testosterone synthesis in
ovarian theca cells.
SET regulated the transcription of steroidogenic enzymes
in theca cells
To determine whether SET regulated testosterone pro-
duction by increasing the expression of steroidogenic
enzymes in theca cells, the mRNA levels of SET and
steroidogenic enzymes, StAR, CYP11A1, CYP17A1, and
HSD3B2, in the follicles infected with AdCMV-SET or
AdCMV, and AdSiRNA-SET or AdSiRNA-NS, were
investigated by qRT-PCR. Compared to the AdCMV
group, the mRNA levels of CYP17A1 and HSD3B2 in
the AdCMV-SET infected group were significantly
augmented following SET overexpression in theca cells
(Figure 3A, p < 0.05). Additionally, down-regulation of
SET with AdSiRNA-SET was accompanied by the sig-
nificantly lowered mRNA levels of CYP17A1 and
HSD3B2 (Figure 3B, p < 0.05). Expression of StAR and
CYP11A1 in groups of both SET overexpression or
knockdown did not change significantly (Figure 3, p >
0.05).
Discussion
The biosynthesis of androgen in ovarian follicles is
regulated by a series of steroidogenic enzymes, such as
P450scc, StAR, HSD3B2, CYP17A1. These enzymeseca cells. (A) Infection of follicular theca cells with recombinant
SET or AdCMV and cultured for 24 h. Over 90% theca cells were
pe. Left: light microscope; right: fluorescence microscope (Scale bar =
ted with recombinant AdCMV-SET adenovirus for 48 h. SET protein
en compared with that in follicles infected with AdCMV. Tubulin was
ynthesis in theca cells. Follicles were infected with AdCMV-SET or
terone production in the culture media of the AdCMV-SET infection
at least 3 independent experiments. *, p < 0.05 compare
Figure 2 Effect of SET knockdown on testosterone synthesis in theca cells. (A) Infection of follicular theca cells with recombinant
adenoviruses. Follicles were infected with recombinant adenovirus AdSiRNA-SET or AdSiRNA-NS and cultured for 24 h. The majority of theca cells
were infected as judged by the expression of GFP under a fluorescence microscope. Left: light microscope; right: fluorescence microscope (Scale
bar = 50 μm). (B) Western blot analysis of SET protein expression in follicles infected with recombinant adenovirus for 48 h. The levels of SET
protein in follicles infected with AdSiRNA-SET were decreased about 43% compared with follicles infected with AdSiRNA-NS. (C) Effect of SET
knockdown on theca cell testosterone synthesis. Compared with the follicles infected with AdSiRNA-NS, the amount of testosterone in the
culture media of the AdSiRNA-SET infection group was significantly degraded. Results are presented as Mean ± SD from at least 3 independent
experiments. Sample sizes were 20 follicles per treatment, per experiment. *, p < 0.05 compare with AdSiRNA-NS infected group.
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tion and play a proposed role in the pathogenic
conditions such as hyperandrogenism in PCOS [6,7].
Previous studies showed that in PCOS theca cells the ex-
pression and activity of the P450c17 and 3β-HSD is
elevated, and the CYP17A1 promoter activity is also
increased [6,25-29], which partly participated in
hyperandrogenism of PCOS. In the past years, much at-
tention has been focused on the regulation of androgen
biosynthesis, while the mechanisms that control the ex-
pression of these steroidogenic enzymes remain notFigure 3 Effect of SET in the regulation of steroidogenic enzyme exp
recombinant adenoviruses for 24 h. The expression of SET, StAR, CYP11A1,
as internal controls. (A) Compared to those receiving AdCMV, the SET mRN
expression of CYP17A1 and HSD3B2 were elevated. (B) The SET mRNA of A
with AdSiRNA-NS and the mRNA levels of CYP17A1 and HSD3B2 decreased
independent experiments. Sample sizes were 20 follicles per treatment, per
infected group.precisely elucidated. In this work, we explored the role
of SET protein in androgen biosynthesis and modulation
of steroidogenic enzymes.
Previous studies have shown that SET was widely
expressed in various tissues, and especially in ste-
roidogenic cells within the central nervous system, adrenal
gland, and gonads. To understand the function of SET
in human ovaries, SET expression patterns had been
examined by immunohistochemistry, which showed that
SET was expressed predominantly in theca cells and
oocytes of the human ovarian follicles (unpublished data).ression in theca cells. The cultured follicles were infected with
CYP17A1 and HSD3B2 were analyzed by qRT-PCR. GAPDH were used
A of AdCMV-SET infected follicles was significantly increased and the
dSiRNA-SET infection group was significantly diminished compared
significantly. Results were presented as Mean ± SD from at least 3
experiment. *, p < 0.05 compared with the control adenoviruses
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Zhang et al. [15] showing that SET was expressed in theca
cells and oocytes of rats. Since the expressions of a variety
of steroidogenic enzymes are cell specific, the primary
function of theca cells is to produce androgen. The ex-
pression of SET in theca cells indicates that SET may be
involved in androgen biosynthesis.
The in vitro culture model of mouse preantral follicles
mimicked the native ovary by maintaining similar struc-
tural integrity. Hormones and paracrine factors produced
by granulosal and/or theca cells can regulate the physio-
logical function of cells located on the opposite side of the
basement membrane. The gene-manipulation procedure
was previously confirmed to effectively deliver ectopical
gene expression in follicular theca cells [23]. In the present
study, we developed the recombinant adenoviruses
AdCMV-SET and AdSiRNA-SET to overexpress or
knockdown SET gene in follicles. Our data firstly showed
that overexpression of SET in theca cells promoted testos-
terone secretion. In contrast, down-regulation of SET led
to a marked reduction in testosterone production. These
results demonstrated that SET played a positive role in
modulating testosterone secretion in follicular theca cells.
In future study we will further examine the change of
other androgens such as pregnenolone, androstenedione
by chromatogram.
In ovarian theca cells, androgen biosynthesis is
mediated by steroidogenic enzymes. Our further studies
indicated that when SET was overexpressed in theca
cells, expressions of CYP17A1 and HSD3B2 were signifi-
cantly increased. As expected, the mRNA levels of
CYP17A1 and HSD3B2 significantly decreased after SET
was silenced in theca cells. Previous studies have shown
that SET, as a novel transcriptional regulator, binds to
the −410/-402 region of the rat CYP17A1 gene along
with the transcription factors COUP-TF II, NGF-IB, and
SF-1, and activates transcription of the rat P450c17 gene
in neuronal precursor cells and mouse Leydig MA-10
cells [13,15,17]. Bioinformatical analysis showed that the
SET binding sequences TCTCCTCAA is also present in
the −312/-320 region of mouse CYP17A1 gene and a
similar sequence ACTCCTCAG is present in the −964/-
959 region of the mouse 3βHSD2 gene. Our present
study indicated that SET may elevate the mRNA levels
of CYP17A1 and HSD3B2 by promoting their transcrip-
tion. Taken together, SET played a positive role in
regulating ovarian androgen biosynthesis by enhancing
transcription of CYP17 and HSD3B2, which may partici-
pate in hyperandrogenism of PCOS.Conclusions
SET played a positive role in regulating ovarian testos-
terone biosynthesis by enhancing the transcription ofsteroidogenic enzymes CYP17A1 and HSD3B2, which
maybe contribute to the hyperandrogenism in PCOS.
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